• ARS Pharmaceuticals (NASDAQ:SPRY) Posts Earnings Results, Beats Estimates By $0.61 EPS

    Source: Buzz FX / 21 Mar 2025 10:26:18   America/Chicago


    ARS Pharmaceuticals (NASDAQ:SPRY) Posts Earnings Results, Beats Estimates By $0.61 EPS Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) announced its quart
    Read more...
Share on,